Completed PHASE3 INTERVENTIONAL NCT00296218

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Randomized Comparison of a Two-month Regimen of Irbesartan Versus Enalapril on Cardiovascular Markers in Patients With Acute Coronary Syndrome Without ST Segment Elevation.

Sponsor: Bristol-Myers Squibb

Conditions Hypertension Myocardial Ischemia

Interventions Irbesartan

Updated 5 times since 2017 Last updated: Oct 14, 2009 Started: Feb 28, 2006 Primary completion: Mar 31, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE3 clinical study on Hypertension and Myocardial Ischemia, this trial is completed. The trial is conducted by Bristol-Myers Squibb and has accumulated 5 data snapshots since 2006. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Feb 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Bristol-Myers Squibb
Sanofi

Data source: Sanofi

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Barcelona, Spain , Berlin, Germany , Bridgewater, United States , Brussels, Belgium , Budapest, Hungary , Gouda, Netherlands , Guildford, United Kingdom , Laval, Canada , Meyrin, Switzerland , Milan, Italy and 1 more location